Neuroone Medical Technologies (NMTC) Total Current Liabilities (2010 - 2026)

Neuroone Medical Technologies' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• Quarterly Total Current Liabilities fell 4.19% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 4.19% YoY) and the FY2025 annual result came in at $2.3 million, up 4.06% from the prior year.
• Total Current Liabilities was $1.7 million for Q1 2026 at Neuroone Medical Technologies, up from $1.3 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $3.1 million in Q3 2022 and bottomed at $810231.0 in Q1 2022.
• A 5-year average of $1.6 million and a median of $1.6 million in 2024 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Current Liabilities jumped 162.22% — and 2023, when it plunged 42.15%.
• Neuroone Medical Technologies' Total Current Liabilities stood at $1.3 million in 2022, then rose by 3.63% to $1.4 million in 2023, then increased by 13.57% to $1.6 million in 2024, then decreased by 19.89% to $1.3 million in 2025, then surged by 34.25% to $1.7 million in 2026.
• Business Quant data shows NMTC's Total Current Liabilities at $1.7 million in Q1 2026, $1.3 million in Q4 2025, and $2.3 million in Q3 2025.